Inspire Medical Systems Inc. logo

Inspire Medical Systems Inc.

INSP | NYSE
Chart Builder DCF Calculator
$75.72
-$1.06 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$75.60
-$0.12 (-0.16%)
Pre-market: Sep 22, 2026, 8:10 AM ET

Market Data

Market Cap
$2.19B
Enterprise Value
$1.9B
Beta
0.70
Average Volume
996.98K
Shares Outstanding (Diluted)
28.94M
Shares Change YoY
-1.92%
Institutional Ownership
N/A
Exchange
NYSE
ISIN
US4577301090

Price Performance

Price Change 1M
23.2%
Price Change 3M
81.4%
Price Change 6M
47.3%
Price Change YTD
-17.9%
Price Change 1Y
-3.6%
Price Change 3Y
-59.1%
Price Change 5Y
-69.3%
1M CAGR (ann.)
25.9%
1Y CAGR (ann.)
-9.2%
5Y CAGR (ann.)
-20.3%
All-Time CAGR
14.1%

Valuation

PE Ratio
16.39
Forward PE
47.32
PEG Ratio
0.10
Forward PEG
0.70
PS Ratio
2.44
Forward PS
2.50
PB Ratio
2.65
P/FCF Ratio
18.70
P/Adj. FCF Ratio
-937.11
P/OCF Ratio
13.89
EV/Sales
2.11
EV/EBIT
28.80
EV/EBITDA
24.17
EV/FCF
16.21
Earnings Yield
6.1%
FCF Yield
5.3%
Adj. FCF Yield
-0.1%

Financial Health

Net Cash
$320.68M
Total Debt
$29.09M
Cash & Short-Term Investments
$320.68M
Total Assets
$925.99M
Current Ratio
8.55
Quick Ratio
6.16
Debt / Equity Ratio
0.04
Debt / EBITDA
0.37
Debt / FCF
0.25
OCF / Debt
5.40
Interest Coverage
406.94
Altman Z-Score
14.74
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
86.1%
Operating Profit Margin
6.0%
EBITDA Margin
9.3%
Net Profit Margin
15.0%
FCF Margin
13.0%
Adj. FCF Margin
-0.3%
SBC / Revenue
13.3%
SBC Impact (per share)
-102.0%

Returns

Return on Assets
14.6%
Return on Equity
17.6%
Return on Invested Capital
6.3%
Return on Capital Employed
6.3%
Return on Tangible Assets
14.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
19.5%
Revenue CAGR 5Y
38.7%
Revenue CAGR 10Y
60.6%
EPS CAGR 3Y
102.0%
EPS CAGR 5Y
224.6%
EPS CAGR 10Y
98.3%
FCF CAGR 3Y
83.5%
FCF CAGR 5Y
91.4%
FCF CAGR 10Y
2959.1%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
27
EPS Growth Next 3Y
-19.4%
Revenue Growth Next 3Y
5.8%
Earnings Date
Nov 1, 2026
EPS Estimate (next Q)
$0.11
EPS Growth Est (next Q)
-71.0%
Revenue Est (next Q)
$204.16M
Revenue Growth Est (next Q)
-9.1%

Fair Value Estimates

Graham Number
$54.55
Graham Upside
-28.0%
Lynch Fair Value
$115.50
Lynch Upside
52.5%
Price Target
$60.80
Price Target Upside
-19.7%

Cash Flow

Operating Cash Flow
$157.07M
Free Cash Flow
$117.09M
Adj. Free Cash Flow
$-2.34M
FCF Per Share
$4.06
OCF Per Share
$5.45
OCF/S Ratio
17.5%

Income Statement

Revenue
$898.74M
Gross Profit
$774.11M
Operating Income
$54.12M
EBITDA
$78.5M
Net Income
$135.04M
EPS (Diluted)
$4.62
Revenue / Employee
$674.23K
Profit / Employee
$101.31K
Employees
1,333

© 2026 bestshares.com. All rights reserved.